Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Response to “The safety of semaglutide in patients with depression and obesity”
Response to “The safety of semaglutide in patients with depression and obesity”
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Robert F. Kushner
,
Thomas A. Wadden
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Obesity
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
The safety of semaglutide in patients with depression and obesity
by: Ziyi Yang, et al.
Published: (2024)
Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study
by: Jamy D. Ard, et al.
Published: (2025)
Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT
by: Thomas A. Wadden, et al.
Published: (2026)
A GLP1R gene variant and sex influence the response to semaglutide treatment in patients with severe obesity
by: Aurélie Phan, et al.
Published: (2025)
Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the STEP 1–4 trials
by: Domenica Rubino, et al.
Published: (2024)
